Thermo Fisher Scientific Long-term debt, gross increased by 9.7% to $43.27B in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates higher long-term leverage, which may impact interest expense and credit ratings.
This is the total gross carrying amount of the firm's long-term debt obligations as reported on the balance sheet. It en...
A core metric for assessing capital structure and solvency compared to industry peers.
other_debt_instrument_carrying_amount| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $39.46B | $43.27B |
| QoQ Change | — | +9.7% |